These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17962624)

  • 1. The mechanistic basis for the disparate effects of angiotensin II on coronary collateral growth.
    Reed R; Kolz C; Potter B; Rocic P
    Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):61-7. PubMed ID: 17962624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of coronary collateral growth in the Zucker obese rat: impact of VEGF and ecSOD.
    Hattan N; Chilian WM; Park F; Rocic P
    Basic Res Cardiol; 2007 May; 102(3):217-23. PubMed ID: 17323199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox-sensitive Akt and Src regulate coronary collateral growth in metabolic syndrome.
    Reed R; Potter B; Smith E; Jadhav R; Villalta P; Jo H; Rocic P
    Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1811-21. PubMed ID: 19376806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth.
    Rocic P; Kolz C; Reed R; Potter B; Chilian WM
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2729-36. PubMed ID: 17308014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane A2/prostaglandin H2 receptor activation mediates angiotensin II-induced postischemic neovascularization.
    Michel F; Silvestre JS; Waeckel L; Corda S; Verbeuren T; Vilaine JP; Clergue M; Duriez M; Levy BI
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):488-93. PubMed ID: 16385086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin type I receptor blockade in conjunction with enhanced Akt activation restores coronary collateral growth in the metabolic syndrome.
    Jadhav R; Dodd T; Smith E; Bailey E; Delucia AL; Russell JC; Madison R; Potter B; Walsh K; Jo H; Rocic P
    Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1938-49. PubMed ID: 21335466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor is required for coronary collateral growth in the rat.
    Toyota E; Warltier DC; Brock T; Ritman E; Kolz C; O'Malley P; Rocic P; Focardi M; Chilian WM
    Circulation; 2005 Oct; 112(14):2108-13. PubMed ID: 16203926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II enhances EGF receptor expression levels via ROS formation in HaCaT cells.
    Nakai K; Yoneda K; Igarashi J; Moriue T; Kosaka H; Kubota Y
    J Dermatol Sci; 2008 Sep; 51(3):181-9. PubMed ID: 18424077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat.
    Yang R; Smolders I; De Bundel D; Fouyn R; Halberg M; Demaegdt H; Vanderheyden P; Dupont AG
    J Hypertens; 2008 May; 26(5):998-1007. PubMed ID: 18398343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of reactive oxygen species (ROS) in angiotensin II-induced stimulation of the cardiac Na+/HCO3- cotransport.
    De Giusti VC; Garciarena CD; Aiello EA
    J Mol Cell Cardiol; 2009 Nov; 47(5):716-22. PubMed ID: 19646989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion?
    Ramalho FS; Alfany-Fernandez I; Casillas-Ramirez A; Massip-Salcedo M; Serafín A; Rimola A; Arroyo V; Rodés J; Roselló-Catafau J; Peralta C
    J Pharmacol Exp Ther; 2009 Apr; 329(1):130-40. PubMed ID: 19116369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
    Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II and new vessel formation: aiming for the right oxidative window.
    Velasquez-Castano JC; Taylor WR
    Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):4-5. PubMed ID: 18094394
    [No Abstract]   [Full Text] [Related]  

  • 15. MMPs 2 and 9 are essential for coronary collateral growth and are prominently regulated by p38 MAPK.
    Dodd T; Jadhav R; Wiggins L; Stewart J; Smith E; Russell JC; Rocic P
    J Mol Cell Cardiol; 2011 Dec; 51(6):1015-25. PubMed ID: 21884701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat.
    Banks T; Oyekan A
    J Hypertens; 2008 Mar; 26(3):468-77. PubMed ID: 18300857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II induces the vascular expression of VEGF and MMP-2 in vivo: preventive effect of red wine polyphenols.
    Walter A; Etienne-Selloum N; Sarr M; Kane MO; Beretz A; Schini-Kerth VB
    J Vasc Res; 2008; 45(5):386-94. PubMed ID: 18354258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
    Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts.
    Sasaoka T; Egi Y; Tawa M; Yamamoto A; Ohkita M; Takaoka M; Maruyama T; Akira T; Matsumura Y
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):176-83. PubMed ID: 18670361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of myosin light chain kinase expression by angiotensin II in hypertension.
    Han YJ; Hu WY; Piano M; de Lanerolle P
    Am J Hypertens; 2008 Aug; 21(8):860-5. PubMed ID: 18511912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.